Insider Trading activities of Genomic Health Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Genomic Health Inc since 2005. The reporting company's ticker symbol is GHDX. The reporting company's CIK number is 1131324.
The total value of stock buying since 2005 is $432,617,427.
The total value of stock sales since 2005 is $68,390,022.
The total value of stock option exercises since 2005 is $13,145,499.



Table 2. Detailed insider stock purchases, sales, and option exercises of Genomic Health Inc insiders (GHDX) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-03-06 Cole G Bradley (COO) Sale 2,500 28.57 71,435
2013-03-06 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-02-21 Baker Bros Advisors Llc (Director) Buy 28,200 27.64 779,335
2013-02-20 Hibbs Kathy L (SVP & General Counsel) Sale 2,716 28.13 76,398
2013-02-20 Baker Bros Advisors Llc (Director) Buy 20,885 27.97 584,216
2013-02-14 Baker Bros Advisors Llc (Director) Buy 34,800 28.43 989,398
2013-02-14 Myers Woodrow A Jr (Director) Sale 41,250 28.40 1,171,541
2013-02-14 Myers Woodrow A Jr (Director) Option Ex 41,250 18.88 778,635
2013-02-13 Baker Bros Advisors Llc (Director) Buy 17,200 28.58 491,593
2013-02-11 Baker Bros Advisors Llc (Director) Buy 79,984 28.23 2,258,108
2013-02-08 Baker Bros Advisors Llc (Director) Buy 36,376 27.96 1,017,109
2013-02-06 Cole G Bradley (COO) Sale 2,500 28.03 70,077
2013-02-06 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2013-01-28 Livingston Randall S (Director) Sale 2,000 28.77 57,544
2013-01-28 Livingston Randall S (Director) Option Ex 2,000 1.33 2,654
2013-01-09 Schorno Dean L (CFO) Sale 2,625 28.00 73,500
2013-01-09 Schorno Dean L (CFO) Option Ex 2,625 9.39 24,648
2013-01-09 Cole G Bradley (COO) Sale 2,500 27.88 69,695
2013-01-09 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-12-18 Shak Steven (EVP of R&D & CMO) Sale 5,000 27.74 138,720
2012-12-13 Popovits Kimberly J (President and CEO) Sale 5,000 28.09 140,440
2012-12-11 Schorno Dean L (CFO) Sale 3,000 28.00 84,000
2012-12-11 Schorno Dean L (CFO) Option Ex 3,000 9.39 28,170
2012-12-06 Cole G Bradley (COO) Sale 2,500 27.18 67,947
2012-12-06 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-11-26 Livingston Randall S (Director) Sale 2,000 27.84 55,684
2012-11-26 Livingston Randall S (Director) Option Ex 2,000 1.33 2,654
2012-11-21 Baker Bros Advisors Llc (Director) Buy 300 27.54 8,262
2012-11-20 Shak Steven (EVP of R&D & CMO) Sale 5,000 27.17 135,845
2012-11-20 Baker Bros Advisors Llc (Director) Buy 229,000 26.83 6,143,383
2012-11-20 Colella Samuel D (Director) Sale 5,500 26.52 145,843
2012-11-19 Colella Samuel D (Director) Sale 25,116 26.97 677,478
2012-11-14 667, L.p. (Director) Buy 103,167 27.32 2,818,212
2012-11-14 Popovits Kimberly J (President and CEO) Sale 5,000 27.24 136,215
2012-11-13 667, L.p. (Director) Buy 103,839 27.99 2,906,661
2012-11-12 667, L.p. (Director) Buy 200,000 27.94 5,587,400
2012-11-12 Schorno Dean L (CFO) Sale 2,800 28.00 78,400
2012-11-12 Schorno Dean L (CFO) Option Ex 2,800 9.39 26,292
2012-11-09 667, L.p. (Director) Buy 519,933 27.05 14,061,587
2012-11-09 Schorno Dean L (CFO) Sale 200 28.00 5,600
2012-11-09 Schorno Dean L (CFO) Option Ex 200 9.39 1,878
2012-11-08 Cole G Bradley (COO) Sale 2,500 28.62 71,542
2012-11-08 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-10-16 Shak Steven (EVP of R&D & CMO) Sale 5,000 35.01 175,055
2012-10-16 Popovits Kimberly J (President and CEO) Sale 5,000 35.00 175,000
2012-10-16 Popovits Kimberly J (President and CEO) Option Ex 5,000 23.31 116,550
2012-10-15 Popovits Kimberly J (President and CEO) Sale 5,000 31.17 155,840
2012-10-12 Schorno Dean L (CFO) Sale 3,000 33.79 101,358
2012-10-12 Schorno Dean L (CFO) Option Ex 3,000 9.39 28,170
2012-10-11 Hibbs Kathy L (SVP & General Counsel) Sale 1,250 33.78 42,223
2012-10-11 Hibbs Kathy L (SVP & General Counsel) Option Ex 1,250 21.07 26,337
2012-10-09 Cole G Bradley (COO) Sale 2,500 34.80 86,990
2012-10-09 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-09-18 Shak Steven (EVP of R&D & CMO) Sale 5,000 33.76 168,800
2012-09-13 Popovits Kimberly J (President and CEO) Sale 5,000 31.69 158,450
2012-09-06 Cole G Bradley (COO) Sale 2,500 35.01 87,515
2012-09-06 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-08-21 Myers Woodrow A Jr (Director) Sale 10,993 35.28 387,800
2012-08-21 Myers Woodrow A Jr (Director) Option Ex 10,993 9.95 109,380
2012-08-20 Shak Steven (EVP of R&D & CMO) Sale 5,000 34.99 174,940
2012-08-20 Myers Woodrow A Jr (Director) Sale 5,507 35.06 193,058
2012-08-20 Myers Woodrow A Jr (Director) Option Ex 5,507 9.95 54,794
2012-08-14 Popovits Kimberly J (President and CEO) Sale 3,103 35.07 108,812
2012-08-14 Popovits Kimberly J (President and CEO) Option Ex 3,103 23.31 72,330
2012-08-13 Popovits Kimberly J (President and CEO) Sale 6,897 34.70 239,312
2012-08-13 Popovits Kimberly J (President and CEO) Option Ex 1,897 23.31 44,219
2012-08-08 Cole G Bradley (COO) Sale 2,500 30.49 76,235
2012-08-08 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-08-01 Cohen Fred E (Director) Option Ex 8,250 10.73 88,522
2012-07-26 Livingston Randall S (Director) Sale 2,000 35.90 71,800
2012-07-26 Livingston Randall S (Director) Option Ex 2,000 1.33 2,654
2012-07-24 Shak Steven (Chief Medical Officer) Sale 5,000 34.24 171,195
2012-07-13 Popovits Kimberly J (President and CEO) Sale 7,100 34.84 247,342
2012-07-13 Popovits Kimberly J (President and CEO) Option Ex 2,100 23.31 48,951
2012-07-11 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 35.16 527,340
2012-07-10 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 36.30 544,575
2012-07-05 Cole G Bradley (COO) Sale 2,500 35.95 89,865
2012-07-05 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-06-25 Shak Steven (Chief Medical Officer) Sale 5,000 33.25 166,250
2012-06-13 Popovits Kimberly J (President and CEO) Sale 5,000 33.36 166,805
2012-06-12 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 33.31 499,650
2012-06-11 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 34.15 512,235
2012-06-06 Cole G Bradley (COO) Sale 2,500 33.97 84,920
2012-06-06 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-05-31 Popovits Kimberly J (President and CEO) Buy 919 23.11 21,239
2012-05-24 Shak Steven (Chief Medical Officer) Sale 5,000 33.80 168,980
2012-05-22 Baker Felix (Director) Buy 17,406 32.94 573,405
2012-05-21 Baker Felix (Director) Buy 150,000 32.12 4,818,450
2012-05-18 Colella Samuel D (Director) Sale 9,300 32.13 298,790
2012-05-17 Colella Samuel D (Director) Sale 16,994 33.52 569,689
2012-05-16 Popovits Kimberly J (President and CEO) Sale 5,000 35.00 175,000
2012-05-16 Popovits Kimberly J (President and CEO) Option Ex 5,000 23.31 116,550
2012-05-16 Baker Felix (Director) Buy 23,621 34.46 813,932
2012-05-15 Schorno Dean L (CFO) Sale 1,000 33.69 33,686
2012-05-15 Popovits Kimberly J (President and CEO) Sale 5,000 33.46 167,290
2012-05-15 Baker Felix (Director) Buy 140,000 33.94 4,752,160
2012-05-14 Baker Felix (Director) Buy 212,438 32.92 6,994,521
2012-05-11 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 30.74 461,145
2012-05-11 Baker Felix (Director) Buy 26,660 30.22 805,558
2012-05-10 Scott Randal W (CEO, InVitae Corporation*) Sale 15,000 30.10 451,560
2012-05-10 Baker Felix (Director) Buy 68,681 29.92 2,054,798
2012-05-09 Cole G Bradley (COO) Sale 2,500 28.87 72,172
2012-05-09 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-05-09 Baker Felix (Director) Buy 19,547 29.89 584,357
2012-05-08 Baker Felix (Director) Buy 86,033 28.60 2,460,543
2012-05-07 Baker Felix (Director) Buy 56,540 28.27 1,598,103
2012-05-04 Baker Felix (Director) Buy 53,128 28.01 1,488,009
2012-04-26 Livingston Randall S (Director) Sale 2,000 28.21 56,428
2012-04-26 Livingston Randall S (Director) Option Ex 2,000 1.33 2,654
2012-04-24 Shak Steven (Chief Medical Officer) Sale 5,000 27.93 139,630
2012-04-23 Popovits Kimberly J (President and CEO) Sale 5,000 27.79 138,965
2012-04-16 Schorno Dean L (CFO) Sale 1,000 27.98 27,980
2012-04-11 Scott Randal W (CEO, InVitae Corporation*) Sale 10,000 28.38 283,790
2012-04-10 Scott Randal W (CEO, InVitae Corporation*) Sale 10,000 29.11 291,130
2012-04-04 Cole G Bradley (COO) Sale 2,500 30.28 75,690
2012-04-04 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-03-22 Shak Steven (Chief Medical Officer) Sale 10,000 30.08 300,830
2012-03-22 Popovits Kimberly J (President and CEO) Sale 10,000 30.07 300,670
2012-03-15 Schorno Dean L (CFO) Sale 1,000 31.08 31,080
2012-03-13 Scott Randal W (CEO, InVitae Corporation) Sale 15,000 31.12 466,770
2012-03-12 Scott Randal W (CEO, InVitae Corporation) Sale 15,000 30.98 464,685
2012-03-08 Cole G Bradley (COO) Sale 2,500 29.94 74,850
2012-03-08 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-03-08 Baker Felix (Director) Buy 22,191 30.36 673,805
2012-03-07 Baker Felix (Director) Buy 25,000 29.88 746,974
2012-03-05 Baker Felix (Director) Buy 177,710 30.01 5,333,432
2012-03-02 Baker Felix (Director) Buy 104,850 29.52 3,095,170
2012-03-01 Baker Felix (Director) Buy 17,456 29.47 514,427
2012-02-29 Baker Felix (Director) Buy 180,603 29.06 5,247,961
2012-02-28 Baker Felix (Director) Buy 58,535 29.11 1,703,835
2012-02-27 Baker Felix (Director) Buy 42,125 29.03 1,222,930
2012-02-24 Popovits Kimberly J (President and CEO) Sale 5,000 28.85 144,255
2012-02-23 Shak Steven (Chief Medical Officer) Sale 5,000 28.14 140,725
2012-02-23 Popovits Kimberly J (President and CEO) Sale 5,000 28.15 140,740
2012-02-23 Baker Felix (Director) Buy 71,214 28.12 2,002,822
2012-02-22 Baker Felix (Director) Buy 6,294 27.98 176,111
2012-02-21 Baker Felix (Director) Buy 53,364 27.98 1,492,964
2012-02-16 Baker Felix (Director) Buy 211,769 29.48 6,242,102
2012-02-15 Schorno Dean L (CFO) Sale 755 28.76 21,713
2012-02-15 Baker Felix (Director) Buy 36,918 28.88 1,066,079
2012-02-14 Baker Felix (Director) Buy 64,620 28.44 1,837,598
2012-02-10 Scott Randal W (Executive Chairman) Sale 10,000 26.25 262,500
2012-02-10 Baker Felix (Director) Buy 188,639 26.58 5,014,212
2012-02-09 Scott Randal W (Executive Chairman) Sale 10,000 26.10 261,030
2012-02-09 Baker Felix (Director) Buy 66,332 26.28 1,743,005
2012-02-08 Cole G Bradley (COO) Sale 2,500 26.47 66,172
2012-02-08 Cole G Bradley (COO) Option Ex 2,500 1.33 3,325
2012-02-08 Baker Felix (Director) Buy 240,570 26.20 6,302,692
2012-01-26 Livingston Randall S (Director) Sale 2,000 27.51 55,020
2012-01-26 Livingston Randall S (Director) Option Ex 2,000 1.33 2,654

Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.